HQY Stock Analysis: Buy, Sell, or Hold?

HQY - HealthEquity, Inc

SERVICES-BUSINESS SERVICES, NEC
$85.67
2.10 (2.51%) β–²
HOLD
MODERATE Confidence
Protect Your HQY Gains
Last Updated: January 30, 2026
Earnings: Mar 17, 2026

Get Alerted When HQY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: HQY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$165.92
Based on 9.8% avg growth
INTRINSIC VALUE TODAY
$103.03
16.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: HQY is currently trading at $85.67, which is considered slightly low relative to its 30-day fair value range of $84.27 to $93.99. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.3) compared to its historical average (22.9). Remarkably, the market is currently pricing in an annual earnings decline of 7.2% over the next few years. This pessimistic expectation contrasts with the company's recent 883.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, HQY is in a strong downtrend. The price is approaching resistance at $88.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: HQY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $119.12 (+42.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $84.27 - $93.99
Company Quality Score 55/100 (HOLD)
Options IV Signal 50th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 59.6%

Protect Your Profits

Holding HQY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Options fairly priced (IV 50th percentile)
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 42.5% below Wall St target ($119.12)

Fair Price Analysis

30-Day Fair Range $84.27 - $93.99
Current vs Fair Value SLIGHTLY LOW
Expected Move (7 Days) Β±$5.26 (6.1%)

Support & Resistance Levels

Support Level $82.23
Resistance Level $88.04
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 18.30
Wall Street Target $119.13 (+42.5%)
Revenue Growth (YoY) 7.2%
Earnings Growth (YoY) 883.3%
Profit Margin 14.9%
Valuation Discount vs History -7.2% cheaper
PE vs Historical 18.3 vs 22.9 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -7.2% (market-implied from PE analysis)
1-Year Target $77.55 (-7%)
2-Year Target $71.97 (-14%)
3-Year Target $66.79 (-20%)
3-Yr Target (if PE normalizes) (PE: 18β†’23) $83.57 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 15.5%) $156.81 (+88%)
Base: (SPY PE: 18.3, Growth: 15.5%) $128.70 (+54%)
Bear: (PE: 15.6, Growth: 15.5%) $109.39 (+31%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 38.00 | Current EPS (TTM): $2.18
Bull Case $182.27 (+113%)
Analyst growth 100.0%, PE expands to 41.8
Base Case $165.70 (+93%)
Market implied 100.0%, PE stable at 38.0
Bear Case $56.34 (-34%)
Severe decline -20.0%, PE contracts to 32.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.3 to 22.9
Stabilization Target: $104.56 (+25.1%)
PE Expansion Potential: +25.1%
Last updated: January 30, 2026 7:50 PM ET
Data refreshes hourly during market hours. Next update: 8:50 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Delano Ladd SELL 1500 shares 2025-10-20
Michael Henry Fiore SELL 1781 shares 2025-10-07
Delano Ladd SELL 6000 shares 2025-09-19

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
32 analysts
$310 54 HOLD
PRVA
Privia Health Group Inc
STRONG BUY
21 analysts
$31 57 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 60 HOLD
PHR
Phreesia Inc
STRONG BUY
15 analysts
$29 48 HOLD
BTSG
BrightSpring Health Serv…
STRONG BUY
12 analysts
$43 63 BUY

Advanced HQY Option Strategies

Professional options setups generated by AI based on today's HQY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for HQY

HQY Technical Chart HQY Price Prediction HQY Earnings Date HQY Investment Advisor HQY Fair Price Analyzer HQY Options Advisor HQY Options Chain HQY Options Analysis HQY Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals